NTBLQ (Notable Labs) Price-to-Operating-Cash-Flow : (As of Dec. 01, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Notable Labs Price-to-Operating-Cash-Flow?

As of today (2024-12-01), Notable Labs's share price is $0.01885. Notable Labs's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.79. Hence, Notable Labs's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Notable Labs's Price-to-Operating-Cash-Flow or its related term are showing as below:

NTBLQ's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.53
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Notable Labs's Cash Flow from Operations per share for the three months ended in Jun. 2024 was $-0.39. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.79.

Notable Labs Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Notable Labs's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs Price-to-Operating-Cash-Flow Chart

Notable Labs Annual Data

Trend

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Notable Labs Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Dec23	Mar24	Jun24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Notable Labs's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Notable Labs's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Notable Labs's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Notable Labs's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Notable Labs's Price-to-Operating-Cash-Flow falls into.

Notable Labs Price-to-Operating-Cash-Flow Calculation

Notable Labs's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.01885	/	-0.787
	=

Notable Labs's Share Price of today is $0.01885.
Notable Labs's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.79.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Notable Labs Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Notable Labs's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Notable Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (OTCPK:NTBLQ) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

320 Hatch Drive, Foster City, CA, USA, 94404

Website

https://notablelabs.com

Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.